This O
hypothesis O
stems O
from O
findings O
that O
PREGS B
is O
a O
potent O
positive O
modulator O
of O
N B
- I
methyl I
- I
d I
- I
aspartate I
receptors O
( O
NMDARs O
) O
and O
a O
negative O
modulator O
of O
gamma B
- I
aminobutyric I
acid I
( O
A O
) O
receptors O
( O
GABA B
( O
A O
) O
Rs O
) O
. O

The O
effects O
of O
dizocilpine B
( O
MK B
- I
801 I
) O
, O
a O
noncompetitive O
N B
- I
methyl I
- I
D I
- I
aspartate I
( O
NMDA B
) O
receptor O
antagonist O
, O
were O
studied O
on O
dopamine B
- O
related O
behaviors O
induced O
by O
reserpine B
treatments O
. O

The O
activation O
of O
spinal O
N B
- I
methyl I
- I
D I
- I
aspartate I
receptors O
may O
contribute O
to O
degeneration O
of O
spinal O
motor O
neurons O
induced O
by O
neuraxial O
morphine B
after O
a O
noninjurious O
interval O
of O
spinal O
cord O
ischemia O
. O

We O
investigated O
the O
relationship O
between O
the O
degeneration O
of O
spinal O
motor O
neurons O
and O
activation O
of O
N B
- I
methyl I
- I
d I
- I
aspartate I
( O
NMDA B
) O
receptors O
after O
neuraxial O
morphine B
following O
a O
noninjurious O
interval O
of O
aortic O
occlusion O
in O
rats O
. O

The O
liver O
levels O
of O
beta O
- O
oxidation O
metabolites O
of O
VPA B
were O
decreased O
by O
day O
14 O
, O
while O
the O
levels O
of O
4 B
- I
ene I
- I
VPA I
and O
( O
E O
) O
- O
2 B
, I
4 I
- I
diene I
- I
VPA I
were O
not O
elevated O
throughout O
the O
study O
. O

Diagnostic O
markers O
such O
as O
N B
- I
terminal I
pro I
brain I
natriuretic I
peptide I
( O
NT B
- I
proBNP I
) O
or O
high O
- O
sensitive O
C O
- O
reactive O
protein O
might O
help O
in O
the O
early O
identification O
of O
patients O
at O
risk O
, O
thus O
avoiding O
the O
occurrence O
of O
serious O
cardiovascular O
toxicity O
. O

Moreover O
, O
both O
hepatitis B
B I
surface I
antigen I
and I
e I
antigen I
were O
observed O
to O
have O
disappeared O
in O
this O
patient O
. O

The O
extent O
of O
neuronal O
injury O
was O
determined O
by O
2 B
, I
3 I
, I
5 I
- I
triphenyltetrazolium I
staining O
. O

Here O
we O
show O
that O
the O
recently O
reported O
ability O
of O
L B
- I
dihydroxyphenylalanine I
to O
reverse O
the O
protective O
effect O
of O
alpha B
- I
methyl I
- I
para I
- I
tyrosine I
on O
METH B
- O
induced O
DA B
neurotoxicity O
is O
also O
confounded O
by O
drug O
effects O
on O
body O
temperature O
. O

Haloperidol B
- O
induced O
catalepsy O
was O
challenged O
with O
prior O
intracollicular O
microinjections O
of O
glutamate B
NMDA B
receptor O
antagonists O
, O
MK B
- I
801 I
( O
15 O
or O
30 O
mmol O
/ O
0 O
. O
5 O
microl O
) O
and O
AP7 B
( O
10 O
or O
20 O
nmol O
/ O
0 O
. O
5 O
microl O
) O
, O
or O
of O
the O
NMDA B
receptor O
agonist O
N B
- I
methyl I
- I
d I
- I
aspartate I
( O
NMDA B
, O
20 O
or O
30 O
nmol O
/ O
0 O
. O
5 O
microl O
) O
. O

The O
glutamatergic O
N B
- I
methyl I
- I
D I
- I
aspartate I
( O
NMDA B
) O
receptor O
has O
been O
implicated O
in O
the O
pathophysiology O
of O
schizophrenia O
. O

Production O
of O
autochthonous O
prostate O
cancer O
in O
Lobund O
- O
Wistar O
rats O
by O
treatments O
with O
N B
- I
nitroso I
- I
N I
- I
methylurea I
and O
testosterone B
. O

More O
than O
50 O
% O
of O
Lobund O
- O
Wistar O
( O
L O
- O
W O
) O
strain O
rats O
developed O
large O
, O
palpable O
prostate O
adenocarcinomas O
( O
PAs O
) O
following O
treatments O
with O
N B
- I
nitroso I
- I
N I
- I
methylurea I
( O
CAS O
: O
684 O
- O
93 O
- O
5 O
) O
and O
testosterone B
propionate I
[ O
( O
TP B
) O
CAS O
: O
57 O
- O
85 O
- O
2 O
] O
, O
and O
most O
of O
the O
tumor O
- O
bearing O
rats O
manifested O
metastatic O
lesions O
. O

Acute O
experimental O
models O
of O
renal O
damage O
to O
the O
proximal O
tubular O
, O
glomerular O
, O
and O
papillary O
regions O
of O
the O
rat O
were O
produced O
by O
administration O
of O
hexachloro B
- I
1 I
: I
3 I
- I
butadiene I
( O
HCBD B
) O
, O
puromycin B
aminonucleoside I
( O
PAN B
) O
, O
and O
2 B
- I
bromoethylamine I
( O
BEA B
) O
, O
respectively O
. O

Tri B
- I
ortho I
- I
tolyl I
phosphate I
( O
TOTP B
) O
, O
360 O
mg O
/ O
kg O
, O
po O
, O
and O
0 B
, I
0 I
' I
- I
diisopropyl I
phosphorofluoridate I
( O
DFP B
) O
, O
1 O
mg O
/ O
kg O
sc O
, O
were O
administered O
to O
adult O
White O
Leghorn O
chickens O
24 O
hr O
after O
they O
were O
placed O
on O
diets O
containing O
0 O
to O
300 O
ppm O
corticosterone B
. O

The O
effect O
of O
aniracetam B
( O
Ro B
13 I
- I
5057 I
, O
1 B
- I
anisoyl I
- I
2 I
- I
pyrrolidinone I
) O
was O
studied O
on O
various O
forms O
of O
experimentally O
impaired O
cognitive O
functions O
( O
learning O
and O
memory O
) O
in O
rodents O
and O
produced O
the O
following O
effects O
: O
( O
1 O
) O
almost O
complete O
prevention O
of O
the O
incapacity O
to O
learn O
a O
discrete O
escape O
response O
in O
rats O
exposed O
to O
sublethal O
hypercapnia O
immediately O
before O
the O
acquisition O
session O
; O
( O
2 O
) O
partial O
( O
rats O
) O
or O
complete O
( O
mice O
) O
prevention O
of O
the O
scopolamine B
- O
induced O
short O
- O
term O
amnesia O
for O
a O
passive O
avoidance O
task O
; O
( O
3 O

Dextromethorphan B
( O
DM B
) O
, O
the O
dextrorotatory O
isomer O
of O
3 B
- I
hydroxy I
- I
N I
- I
methylmorphinan I
, O
is O
the O
main O
ingredient O
in O
a O
number O
of O
widely O
available O
, O
over O
- O
the O
- O
counter O
antitussives O
. O

Moreover O
, O
KF17837 B
( O
0 O
. O
625 O
mg O
/ O
kg O
p O
. O
o O
. O
) O
potentiated O
the O
anticataleptic O
effects O
of O
a O
subthreshold O
dose O
of O
L B
- I
3 I
, I
4 I
- I
dihydroxyphenylalanine I
( O
L B
- I
DOPA I
; O
25 O
mg O
/ O
kg O
i O
. O
p O
. O
) O
plus O
benserazide B
( O
6 O
. O
25 O
mg O
/ O
kg O
i O
. O
p O
. O
) O
. O

Although O
most O
of O
the O
hepatomas O
were O
well O
- O
differentiated O
tumors O
and O
contained O
a O
considerable O
number O
of O
peroxisomes O
, O
the O
tumor O
cells O
did O
not O
respond O
to O
ethyl B
- I
alpha I
- I
p I
- I
chlorophenoxyisobutyrate I
with O
proliferation O
of O
peroxisomes O
. O

No O
abnormal O
matrical O
inclusions O
of O
peroxisomes O
were O
formed O
in O
the O
cells O
of O
hyperplastic O
nodules O
by O
ethyl B
- I
alpha I
- I
p I
- I
chlorophenoxyisobutyrate I
unlike O
in O
the O
case O
of O
rats O
. O

Cardiac O
function O
was O
assessed O
in O
long O
- O
term O
survivors O
of O
malignant O
bone O
tumors O
who O
were O
treated O
according O
to O
Rosen B
' I
s I
T5 I
or I
T10 I
protocol I
, O
both O
including O
doxorubicin B
. O

Superoxide B
and O
hydrogen B
peroxide I
production O
in O
neutrophils O
stimulated O
with O
formyl B
- I
methionyl I
- I
leucyl I
- I
phenylalanine I
( O
fMLP B
) O
from O
a O
further O
18 O
ALF O
patients O
was O
unaffected O
compared O
with O
control O
neutrophils O
. O

Several O
structurally O
related O
metabolites O
of O
progesterone B
( O
3 B
alpha I
- I
hydroxy I
pregnane I
- I
20 I
- I
ones I
) O
and O
deoxycorticosterone B
( O
3 B
alpha I
- I
hydroxy I
pregnane I
- I
21 I
- I
diol I
- I
20 I
- I
ones I
) O
and O
their O
3 O
beta O
- O
epimers O
were O
evaluated O
for O
protective O
activity O
against O
pilocarpine B
- O
, O
kainic B
acid I
- O
and O
N B
- I
methyl I
- I
D I
- I
aspartate I
( O
NMDA B
) O
- O
induced O
seizures O
in O
mice O
. O

